1. Stocks
  2. Solara Active Pharma Sciences Ltd.
  3. Swot
swot-logo

Solara Active Pharma Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Solara Active Pharma Sciences Ltd. has 18 Strengths, 10 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Newly Affordable Stocks with Good Financials and Durability (subscription)

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

High Return, Short-term Strategy with Piotroski Score, SMA and RSI (Higher Risk)

Stocks gaining versus previous close, open price and RSI

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with decreasing Promoter pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

RSI indicating price strength

High Volume, High Gain

Top Gainers

Volume Shockers

Insiders bought stocks

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Declining Revenue every quarter for the past 3 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

High promoter stock pledges

Stocks Underperforming their Industry Price Change in the Quarter

Promoters increasing shareholding QoQ

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)